Published in Clin Infect Dis on January 01, 1999
A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients | NCT02527005
Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis | NCT03278808
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ (2003) 2.87
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2002) 1.53
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother (2006) 1.46
In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother (2001) 1.45
Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg (2011) 1.43
Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. Am J Trop Med Hyg (2010) 1.41
Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J (2008) 1.37
Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother (2012) 1.30
Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun (2004) 1.18
Extracts from "Clinical Evidence". Malaria: prevention in travellers. BMJ (2000) 1.10
Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert Opin Drug Metab Toxicol (2011) 1.01
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki. Ther Clin Risk Manag (2008) 0.99
Pharmacokinetic properties of azithromycin in pregnancy. Antimicrob Agents Chemother (2009) 0.98
Review: Malaria chemoprophylaxis for travelers to Latin America. Am J Trop Med Hyg (2011) 0.96
Triangular test applied to the clinical trial of azithromycin against relapses in Plasmodium vivax infections. Malar J (2002) 0.92
Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis. Antimicrob Agents Chemother (2005) 0.86
Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. Antimicrob Agents Chemother (2003) 0.84
Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: a cluster-randomized trial. Am J Trop Med Hyg (2014) 0.80
Could a simple antenatal package combining micronutritional supplementation with presumptive treatment of infection prevent maternal deaths in sub-Saharan Africa? BMC Pregnancy Childbirth (2007) 0.79
Malaria: prevention in travellers. BMJ Clin Evid (2007) 0.77
Tetracyclines in malaria. Malar J (2015) 0.77
Malaria: prevention in travellers. BMJ Clin Evid (2010) 0.77
Optimal seasonal timing of oral azithromycin for malaria. Am J Trop Med Hyg (2014) 0.76
Structure and conformational analysis of spiroketals from 6-O-methyl-9(E)-hydroxyiminoerythronolide A. Beilstein J Org Chem (2015) 0.75
Azithromycin for Malaria? Am J Trop Med Hyg (2016) 0.75
Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania. Emerg Infect Dis (2014) 0.75
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling. Antimicrob Agents Chemother (2017) 0.75
Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study. Malar J (2016) 0.75
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90
Action of nicking-closing enzyme on supercoiled and nonsupercoiled closed circular DNA: formation of a Boltzmann distribution of topological isomers. Proc Natl Acad Sci U S A (1975) 6.26
The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ (2011) 5.95
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med (1999) 5.02
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet (2007) 4.85
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg (1997) 3.61
Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. Am J Trop Med Hyg (1997) 3.56
Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 3.46
Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol (2000) 3.39
Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg (1991) 3.31
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis (2007) 3.27
A statistical paradigm for neural spike train decoding applied to position prediction from ensemble firing patterns of rat hippocampal place cells. J Neurosci (1998) 3.20
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg (2006) 3.08
Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science (1998) 3.04
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity (1997) 2.93
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia (2010) 2.83
Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother (2008) 2.77
Carotid endarterectomy. Clinical results in a community-based teaching hospital. Stroke (1988) 2.77
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J (1998) 2.62
Comparison of the ParaSight-F test and the ICT Malaria Pf test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers. Trans R Soc Trop Med Hyg (1998) 2.56
Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology (1994) 2.55
Negative regulation of defense responses in plants by a conserved MAPKK kinase. Proc Natl Acad Sci U S A (2001) 2.51
Diagnosis of malaria in the field by fluorescence microscopy of QBC capillary tubes. Trans R Soc Trop Med Hyg (1992) 2.39
Cassettes for PCR-mediated construction of green, yellow, and cyan fluorescent protein fusions in Candida albicans. Yeast (2001) 2.37
A yeast telomere binding activity binds to two related telomere sequence motifs and is indistinguishable from RAP1. Curr Genet (1989) 2.31
Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg (2001) 2.30
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ (2009) 2.30
Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.28
Chromatin assembly factor I contributes to the maintenance, but not the re-establishment, of silencing at the yeast silent mating loci. Genes Dev (1998) 2.25
RLF2, a subunit of yeast chromatin assembly factor-I, is required for telomeric chromatin function in vivo. Genes Dev (1997) 2.23
Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet (1993) 2.23
Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J Cell Biol (1998) 2.16
Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology (2005) 2.13
Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Biochem Biophys Res Commun (1991) 2.12
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Improving clinical teaching. Evaluation of a national dissemination program. Arch Intern Med (1992) 2.04
Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workers. Arthritis Rheumatol (2015) 2.02
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Antimicrob Agents Chemother (2007) 2.02
Detection of Shigellae and enteroinvasive Escherichia coli by amplification of the invasion plasmid antigen H DNA sequence in patients with dysentery. J Infect Dis (1993) 1.97
Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis (2008) 1.96
Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 1.95
Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis (2001) 1.94
Identification of a telomere-binding activity from yeast. Proc Natl Acad Sci U S A (1986) 1.94
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci U S A (1998) 1.93
Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg (1991) 1.87
Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis (1995) 1.87
Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg (1990) 1.85
Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg (1998) 1.82
Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis (2006) 1.82
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med (1998) 1.81
A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology (2005) 1.81
Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. J Infect Dis (1995) 1.81
Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans R Soc Trop Med Hyg (1996) 1.76
In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg (1997) 1.74
Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser (1994) 1.73
Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst (1994) 1.72
Intensive Therapy for Early Syphilis. Br Med J (1943) 1.71
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax. Antimicrob Agents Chemother (2010) 1.70
Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J Infect Dis (1998) 1.65
Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A (2001) 1.63
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J Virol (1996) 1.60
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis (2001) 1.60
Ultrastructural study of guinea pig tracheal smooth muscle and its innervation. Can J Physiol Pharmacol (1980) 1.57
Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg (2001) 1.57
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis (1998) 1.55
Periampullary malignancy in Gardner's syndrome. Ann Surg (1977) 1.53
The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med (1997) 1.51
Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol Appl Pharmacol (2005) 1.51
The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis (2000) 1.49
Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites. J Virol (1993) 1.47
Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging (2001) 1.47
Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene (2006) 1.45
Cost-effectiveness of artesunate for the treatment of severe malaria. Trop Med Int Health (2009) 1.43
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science (1991) 1.43
Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol (1998) 1.42
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41
Failure of the 'pan-malarial' antibody of the ICT Malaria P.f/P.v immunochromatographic test to detect symptomatic Plasmodium malariae infection. Trans R Soc Trop Med Hyg (2000) 1.41
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. Vaccine (2009) 1.41
Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis (2001) 1.40
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol (1986) 1.40
The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology (1997) 1.40